Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy

Lancet Oncol. 2020 Mar;21(3):e130. doi: 10.1016/S1470-2045(20)30072-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase 6*
  • Ethnicity*
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • CDK4 protein, human
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase 6